Results indicated a significant increase in PD-1+CD4+ and PD-1+CD8+ T cell proportions within the tumour one day after SBRT completion, but a significant decrease in PD-1+CD8+ T cells seven days post-radiotherapy (66). This evidence concerns the gene PDCD1 and neoplasm.